AMD and Intel Recently Reported Earnings -- but There Was Only 1 Clear WinnerThe Motley Fool • 11/12/24
Age-Related Macular Degeneration (AMD) Drugs Market Research 2024: Lucentis, Eylea, Eylea HD, Vabysmo, Syfovre, Ranibizumab, Aflibercept, Faricimab, Biologic, Biosimilar - Global Forecast to 2029GlobeNewsWire • 11/08/24
AMD Plunges 17% in a Month: Is the Stock Worth Buying on the Dip?Zacks Investment Research • 11/06/24
These 2 Stocks Are Nvidia's Most Serious Competitors. But Are They Even Close?The Motley Fool • 11/06/24
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve VisionBusiness Wire • 11/04/24
Taiwan Server System Industry Analysis Report 2024 - Explore the Strategic Implications of AMD's Acquisition of ZT SystemsGlobeNewsWire • 11/04/24